Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsFunctional Brain Connectivity StudiesAdvanced Neuroimaging Techniques and ApplicationsBioinformatics and Genomic Networks
Publications
168
Citations
7,506
Est. group size
~1
Recurring co-author estimate
Active years
92
Publishing since 1935
Publication cadence
Publications per year over the last 10 years — averaging 10.0/year recently
Recent publications
- Retraction notice to “Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying the PSEN1 H163R mutation” [Stem Cell Res. 79 (2024) 103495]
Stem Cell Research · 2026
- Implementing early detection of cognitive impairment in primary care to improve care for older adults
Journal of Internal Medicine · 2025
- Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer’s disease
Alzheimer s Research & Therapy · 2025
- Towards Identifying an Optimal Time for Amyloid Assessment with Donanemab Treatment (S23.004)
Neurology · 2025
- Multiple‐Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid‐Beta Precursor Protein for Alzheimer’s Disease
Alzheimer s & Dementia · 2025
- Single ascending dose results from an ongoing Phase 1 study of mivelsiran (ALN‐APP), the first investigational RNA interference therapeutic targeting amyloid precursor protein for Alzheimer’s disease
Alzheimer s & Dementia · 2024
- RETRACTED: Generation of a gene-corrected human isogenic iPSC line from an Alzheimer’s disease iPSC line carrying the PSEN1 H163R mutation
Stem Cell Research · 2024
- Implementing Digital Cognitive Assessments to Detect Cognitive Impairment: Results from the Davos Alzheimer’s Collaborative Early Detection Program
Alzheimer s & Dementia · 2024
- Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials
The Journal of Prevention of Alzheimer s Disease · 2024
- Donanemab in Early Symptomatic Alzheimer Disease
JAMA · 2023
- Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer’s disease
Brain · 2023
- Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease
European Journal of Nuclear Medicine and Molecular Imaging · 2023
- Interim phase 1 part A results for ALN‐APP, the first investigational RNAi therapeutic in development for Alzheimer’s disease
Alzheimer s & Dementia · 2023
- Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid
Nature · 2022
- Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease
NeuroImage · 2022
Publishes in
- Alzheimer s & Dementia×41
- medRxiv×5
- The Lancet Neurology×3
- Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring×3
- Nature Communications×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile